GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC thumbnail

GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC

Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…

How illegal dispensaries are a threat to the legal cannabis industry thumbnail

How illegal dispensaries are a threat to the legal cannabis industry

The booming business of cannabis is what many investors are calling the new gold rush. But with those potential riches comes this reality: there’s a much bigger boom in the…

US Officials could be ready to crack down on cannabis craze thumbnail

US Officials could be ready to crack down on cannabis craze

Are US border officials cracking down on the cannabis industry? Pot stocks get smoked. With CNBC’s Aditi Roy and Scott Wapner, and the Fast Money traders, Pete Najarian, Tim Seymour,…

Inside one of the biggest cannabis investor conferences thumbnail

Inside one of the biggest cannabis investor conferences

The cannabis buzz. Is regulation a catalyst for pot stocks? Is it time to buy? With FM trader Tim Seymour, CNBC’s Melissa Lee and the Fast Money traders, Dan Nathan,…

How midterm elections could impact the cannabis business thumbnail

How midterm elections could impact the cannabis business

Vivien Azer, Cowen senior research analyst, and CNBC’s Aditi Roy join ‘Squawk Alley’ to discuss how cannabis regulation could be affected by the midterm elections, specifically in Utah, North Dakota,…

Cannabis reclassification is 'a real milestone' for the industry," says Curaleaf's Boris Jordan thumbnail

Cannabis reclassification is ‘a real milestone’ for the industry,” says Curaleaf’s Boris Jordan

Boris Jordan, co-founder and executive chairman of Curaleaf, joins ‘Squawk on the Street’ to discuss the significance of cannabis’ reclassification, the federal tax code around cannabis, and much more.

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC thumbnail

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC

The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…

GW Pharma CEO on new cannabis-derived drug thumbnail

GW Pharma CEO on new cannabis-derived drug

GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says about the future of cannabis-derived drugs.

Firing up the cannabis trade thumbnail

Firing up the cannabis trade

Trader Tim Seymour on why he’s long a number of cannabis stocks. With CNBC’s Courtney Reagan and the Fast Money traders, Victoria Fernandez and Delano Saporu. For access to live…

Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC thumbnail

Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC

He’s spent time in the C-Suite at Victoria’s Secret and DSW, and now, he’s turning his attention to cannabis. Jim Cramer finds out what retailers can bring to the table…